These studies suggest that BPC-157 can help accelerate the healing of muscles, tendons, ligaments, and even the lining of the gastrointestinal tract
10.3389/fpsyt.2022.998195 42 DepinoA
Research Administration and Dosing Considerations Published research on BPC-157 in animal models has used various administration routes: Intraperitoneal injection: Common in rodent studies but impractical for veterinary application Subcutaneous injection: More relevant to potential veterinary use Intramuscular injection: Studied in some larger animal models Oral administration: Some research suggests oral bioavailability, though data is limited Topical application: Investigated for wound healing applications Dosing in animal studies varies widely (typically reported as g/kg body weight), and optimal dosing for dogs specifically has not been established through controlled veterinary trials
Clinical trials demonstrate superior weight reduction versus either agent alone, with the combination targeting complementary satiety pathways [1] [2]
It has been suggested that administration of large amounts or improper combinations of AOXs may lead to shift of the redox balance towards a reductive stress status (31)
Many clinics use weekly patterns, but the right schedule (if any) should be individualized after a consult
